5.0(top 5%)
impact factor
548(top 50%)
papers
13.8K(top 20%)
citations
55(top 10%)
h-index
5.1(top 5%)
impact factor
771
all documents
15.8K
doc citations
90(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Regulation of immune cell function by short‐chain fatty acidsClinical and Translational Immunology2016885
2Detection of IgM and IgG antibodies in patients with coronavirus disease 2019Clinical and Translational Immunology2020281
3Furin‐mediated protein processing in infectious diseases and cancerClinical and Translational Immunology2019231
4Microbiome effects on immunity, health and disease in the lungClinical and Translational Immunology2017225
5Toll‐like receptors: the swiss army knife of immunity and vaccine developmentClinical and Translational Immunology2016216
6Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerationsClinical and Translational Immunology2019205
7Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseasesClinical and Translational Immunology2016196
8Dengue virus antibodies enhance Zika virus infectionClinical and Translational Immunology2016179
9Maternal and infant infections stimulate a rapid leukocyte response in breastmilkClinical and Translational Immunology2013172
10Infectious mononucleosisClinical and Translational Immunology2015167
11MAIT cells: new guardians of the liverClinical and Translational Immunology2016160
12Targeting dendritic cells: a promising strategy to improve vaccine effectivenessClinical and Translational Immunology2016152
13Chronic mucocutaneous candidiasis disease associated with inborn errors of IL‐17 immunityClinical and Translational Immunology2016148
14Vaccines to prevent leishmaniasisClinical and Translational Immunology2014142
15Roles of the intestinal microbiota in pathogen protectionClinical and Translational Immunology2017142
16From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH‐F3+GLA‐SEClinical and Translational Immunology2015131
17Epstein–barr virus vaccinesClinical and Translational Immunology2015128
18Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapyClinical and Translational Immunology2014120
19Recent novel approaches to limit oxidative stress and inflammation in diabetic complicationsClinical and Translational Immunology2018119
20Immune microenvironment composition in non‐small cell lung cancer and its association with survivalClinical and Translational Immunology2020119
21Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort studyClinical and Translational Immunology2020111
22Clinical immune‐monitoring strategies for predicting infection risk in solid organ transplantationClinical and Translational Immunology2014107
23Caspase‐8: not so silently deadlyClinical and Translational Immunology2017105
24Lessons from ten years of genome‐wide association studies of asthmaClinical and Translational Immunology2017103
25OX40, PD‐1 and CTLA‐4 are selectively expressed on tumor‐infiltrating T cells in head and neck cancerClinical and Translational Immunology2016102
26Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseasesClinical and Translational Immunology201696
27Regulatory T‐cell heterogeneity and the cancer immune responseClinical and Translational Immunology201796
28Clinical application of genetically modified T cells in cancer therapyClinical and Translational Immunology201494
29Human FOXP3+ T regulatory cell heterogeneityClinical and Translational Immunology201893
30Treg activation defect in type 1 diabetes: correction with TNFR2 agonismClinical and Translational Immunology201691
31Embracing the gut microbiota: the new frontier for inflammatory and infectious diseasesClinical and Translational Immunology201790
32Defective T‐cell control of Epstein–Barr virus infection in multiple sclerosisClinical and Translational Immunology201790
33Transforming growth factor β: a master regulator of the gut microbiota and immune cell interactionsClinical and Translational Immunology201789
34Cytokines in type 1 diabetes: mechanisms of action and immunotherapeutic targetsClinical and Translational Immunology202088
35Endothelial cells are not productively infected by SARS‐CoV‐2Clinical and Translational Immunology202188
36Bacterial lipodipeptide, Lipid 654, is a microbiome‐associated biomarker for multiple sclerosisClinical and Translational Immunology201387
37New insights into therapeutic strategies for gut microbiota modulation in inflammatory diseasesClinical and Translational Immunology201685
38Genome‐wide association studies in Crohn's disease: Past, present and futureClinical and Translational Immunology201880
39Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patientsClinical and Translational Immunology202179
40Interleukin‐6: a new therapeutic target in systemic sclerosis?Clinical and Translational Immunology201378
41Clinical development methodology for infusion‐related reactions with monoclonal antibodiesClinical and Translational Immunology201577
42Local innate immune responses in the vaccine adjuvant‐injected muscleClinical and Translational Immunology201677
43Infiltrating monocytes in liver injury and repairClinical and Translational Immunology201675
44Endoplasmic reticulum stress in the development of multiple myeloma and drug resistanceClinical and Translational Immunology201874
45Adoptive T‐cell therapy: adverse events and safety switchesClinical and Translational Immunology201473
46Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathwayClinical and Translational Immunology201672
47Guanylate‐binding protein 5 is a marker of interferon‐γ‐induced classically activated macrophagesClinical and Translational Immunology201671
48Type 1 diabetes genome‐wide association studies: not to be lost in translationClinical and Translational Immunology201770
49Plasmacytoid dendritic cell biology and its role in immune‐mediated diseasesClinical and Translational Immunology202070
50Stem memory T cells (TSCM)—their role in cancer and HIV immunotherapiesClinical and Translational Immunology201468